Wikidata

(Q43047576)

English

Histological benefits of virological response to peginterferon alfa-2a monotherapy in patients with hepatitis C and advanced fibrosis or compensated cirrhosis

scientific article published on 17 January 2008

In more languages

Statements

title
Histological benefits of virological response to peginterferon alfa-2a monotherapy in patients with hepatitis C and advanced fibrosis or compensated cirrhosis (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
18208570
retrieved
12 November 2017
author name string
G T Everson
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
18208570
retrieved
12 November 2017
L Balart
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
18208570
retrieved
12 November 2017
R W Reindollar
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
18208570
retrieved
12 November 2017
M L Shiffman
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
18208570
retrieved
12 November 2017
G Y Minuk
series ordinal
6
1 reference
stated in
Europe PubMed Central
PubMed ID
18208570
retrieved
12 November 2017
P J Pockros
series ordinal
7
1 reference
stated in
Europe PubMed Central
PubMed ID
18208570
retrieved
12 November 2017
S Govindarajan
series ordinal
8
1 reference
stated in
Europe PubMed Central
PubMed ID
18208570
retrieved
12 November 2017
E J Heathcote
series ordinal
10
1 reference
stated in
Europe PubMed Central
PubMed ID
18208570
retrieved
12 November 2017
publication date
17 January 2008
1 reference
stated in
Europe PubMed Central
PubMed ID
18208570
retrieved
12 November 2017
page(s)
542-551
1 reference
stated in
Europe PubMed Central
PubMed ID
18208570
retrieved
12 November 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q43047576&oldid=1978754416"